CATEGORY
MHRA
- ABPI
- ACE
- ACIS
- Adelaide
- Aetsa
- Agenas
- AHRQ
- AIFA
- AMNOG
- ANVISA
- AOTMiT
- AQuAS
- Behandlingsraadet
- BfArM
- Biocat
- C2H
- CADTH
- CDC
- CDE
- CMS
- COFEPRIS
- CONITEC
- Digemid
- EFPIA
- EMA
- EPF
- Eucope
- EUnetHTA
- EuropaBio
- European Commission
- Euskadi
- FDA
- FOPH
- G-BA
- Gesundheit Österreich
- HAS
- Health Technology Wales
- Healthcare Improvement Scotland
- HHS
- HIQA
- HTAi
- ICER
- IECS
- IETS
- IHE
- IHEA
- INAHTA
- IQWiG
- ISPOR
- KCE
- Medicaid
- Medicines for Europe
- MHRA
- MSP
- NECA
- NHS
- nHTA
- NICE
- NIH
- NIHO
- NIHR
- NIPH
- NSW Health
- NZa
- OHE
- OYS
- PBS
- pCPA
- Pharmac
- PhRMA
- Salute
- SBU
- Schönermark Kielhorn Collegen
- SGK
- TÄ°TCK
- TLV
- WHO
- ZonMw
- Zorginstituut Nederland
NICE Recommends Alectinib to Prevent ALK-Positive Lung Cancer Recurrence
NICE Challenges Donanemab’s Value for Alzheimer’s Treatment in NHS
Vabysmo Shows Promising Results for Underrepresented Groups in DME Treatment
UK Launches Pioneering mRNA Norovirus Vaccine Trial
Advancements in AI Technology Reshape Industries Worldwide
MHRA Approves Elafibranor as First Treatment for Primary Biliary Cholangitis
MHRA Urges Immediate Reporting of Safety Concerns with Glucose Monitors and Insulin Pumps
MHRA Approves First-Ever Treatment for Rare Immune Disorder APDS Through Fast-Track Process
ABPI Preparing for the Windsor Framework: Ensuring Smooth UK Medicines Supply Beyond 2025
Defining Purpose and Use in Medical Device Regulation: A Critical Perspective
Aspivix’s Carevix Device Receives MHRA Approval, Expanding Gynecological Care in the UK